Related Experiment Video

Updated: Feb 24, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

24.0K

ERS statement on protracted bacterial bronchitis in children

Ahmad Kantar1,2, Anne B Chang3,4,5,2, Mike D Shields6

  • 1Pediatric Asthma and Cough Centre, Istituti Ospedalieri Bergamaschi, University and Research Hospitals, Bergamo, Italy kantar@centropediatricotosse.com.

The European Respiratory Journal
|August 26, 2017
PubMed

Insights

This European Respiratory Society statement offers a comprehensive overview of protracted bacterial bronchitis (PBB) in children, summarizing current knowledge and treatment strategies. It highlights key areas for future research to improve understanding and management of PBB.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases

Background:

  • Protracted bacterial bronchitis (PBB) is a common respiratory condition in children.
  • Current understanding of PBB's definition, pathobiology, and optimal management requires further clarification.

Purpose of the Study:

  • To provide a comprehensive overview of protracted bacterial bronchitis (PBB) in children.
  • To synthesize current knowledge on PBB definition, microbiology, pathobiology, and treatment.
  • To identify key areas for future research in PBB.

Main Methods:

  • A European Respiratory Society task force of experts was convened.
  • Systematic reviews were conducted to address key questions regarding PBB.
  • Findings were summarized, and consensus was reached on the statement content.

Main Results:

  • The statement presents the current definition, microbiology, and pathobiology of PBB.
  • Bronchoalveolar lavage findings and current treatment strategies are detailed.
  • Evidence supporting the definition of PBB is presented.

Conclusions:

  • Further research is needed to establish the disease burden and natural history of PBB.
  • A better understanding of PBB's underlying mechanisms and optimized treatment strategies are required.
  • Randomized controlled trials in primary care are essential for advancing PBB management.

More Related Videos

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

1.5K
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.6K

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
4.1K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
907
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.4K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K